SAMPLE TABLES
TABLE 1 LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE , BY REGION , 2013 – 2020 ( USD MILLION )
REGION 2013 2014 2015-e 2020-p
CAGR ( 2015 – 2020 )
NORTH AMERICA |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
EUROPE |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
ASIA-PACIFIC |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
ROW |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
TOTAL |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
Sources : WHO , OECD , EHN , the World Bank , U . S . Census Bureau , Offices of National Statistics ( U . K .), Annual Reports , SEC Filings , Press Releases , Investor Presentations , Journals , Expert Interviews , and MarketsandMarkets Analysis
TABLE 2 U . S .: HUMAN INSULIN DRUGS MARKET SIZE , BY PRODUCT , 2013 – 2020 ( USD MILLION )
PRODUCT 2013 2014 2015-e 2020-p
CAGR ( 2015 – 2020 )
INSULIN ANALOGS & BIOSIMILARS xx . x xx . x xx . x xx . x xx . x % HUMAN INSULIN BIOLOGICS xx . x xx . x xx . x xx . x xx . x % TOTAL xx . x xx . x xx . x xx . x xx . x %
Sources : WHO , OECD , EHN , the World Bank , U . S . Census Bureau , Annual Reports , SEC Filings , Press Releases , Investor Presentations , Journals , Expert Interviews , and MarketsandMarkets Analysis
TABLE 3 EUROPE : HUMAN INSULIN MARKET SIZE , BY COUNTRY , 2013 – 2020 ( USD MILLION )
COUNTRY / REGION 2013 2014 2015-e 2020-p
CAGR ( 2015 – 2020 )
GERMANY |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
FRANCE |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
U . K . |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
ROE |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
TOTAL |
xx . x |
xx . x |
xx . x |
xx . x |
xx . x % |
Sources : WHO , OECD , EHN , the World Bank , Offices of National Statistics ( U . K .), Annual Reports , SEC Filings , Press Releases , Investor Presentations , Journals , Expert Interviews , and MarketsandMarkets Analysis
sales @ marketsandmarkets . com www . marketsandmarkets . com
25